<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02803814</url>
  </required_header>
  <id_info>
    <org_study_id>DUOPAN-EPAM</org_study_id>
    <nct_id>NCT02803814</nct_id>
  </id_info>
  <brief_title>Pancreatoduodenectomy in Pancreatic and Periampullary Tumors</brief_title>
  <acronym>DUOPAN-EPAM</acronym>
  <official_title>Pancreatoduodenectomy in Pancreatic and Periampullary Tumors: Initial Approach of the Superior Mesenteric Artery Versus Classical Approach: A Prospective, Randomized, Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación para la Investigación del Hospital Clínico de Valencia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundación para la Investigación del Hospital Clínico de Valencia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Recently it has been observed in pancreatic cancer that after apparently complete
      surgical resection, histological examination of the surgical specimen according to a standard
      protocol reveals tumor infiltration of the surgical margin in more than 50% of patients. To
      increase the resection margin and reduce such high infiltration rate, a new surgical approach
      based on the initial dissection of the superior mesenteric artery has been advocated.

      Aims: To compare the rate of free resection margin (R0) and oncological results of two
      possible approaches to perform a pancreaticoduodenectomy in tumors of the head of the
      pancreas and peripancreatic area: the classic approach versus the initial approach of the
      superior mesenteric artery.

      Methodology: Prospective, randomized, multicenter study in which patients with pancreatic and
      periampullary tumors undergo a pancreaticoduodenectomy. In a group the classical approach
      from the superior mesenteric vein will be performed and in the other group an initially
      dissecting the superior mesenteric artery approach will be carried out. 116 patients are
      required and the main variables considered are: free margin rates (R0) or infiltrated by
      tumor (R1), postoperative morbidity, mortality, local and systemic recurrence, disease-free
      interval and survival at 1, 3 and 5 years.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of free resection margin (R0)</measure>
    <time_frame>1 month</time_frame>
    <description>Histological examination of the surgical specimen</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>Pancreatic and Periampullary Tumors</condition>
  <arm_group>
    <arm_group_label>Superior mesenteric artery approach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Initial approach of the superior mesenteric artery to perform a pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Classic approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Classic approach to perform a pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Superior mesenteric artery approach for pancreatoduodenectomy</intervention_name>
    <description>Pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area using the superior mesenteric artery approach</description>
    <arm_group_label>Superior mesenteric artery approach</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Classic approach for pancreatoduodenectomy</intervention_name>
    <description>Pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area using the classical approach</description>
    <arm_group_label>Classic approach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with pancreatic and periampullary tumors undergo a pancreaticoduodenectomy

        Exclusion Criteria:

          -  Patients with hepatic or peritoneal metastasis

          -  Patients with irresectable tumor

          -  Patients with R2 resection

          -  Patients Grade IV of the American Society of Anesthesiology Score

          -  Patients with neoadjuvant treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2016</study_first_posted>
  <last_update_submitted>February 19, 2018</last_update_submitted>
  <last_update_submitted_qc>February 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pancreatoduodenectomy</keyword>
  <keyword>Pancreatic tumors</keyword>
  <keyword>Periampullary tumors</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancrelipase</mesh_term>
    <mesh_term>Pancreatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

